According to Zhitong Finance APP, Guangdong Jiaying Pharmaceutical (002198.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue of 0.18 billion yuan, a decrease of 30.00% compared to the same period last year. The net income attributable to shareholders of the listed company was 5.6677 million yuan, a decrease of 68.94% compared to the same period last year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.1626 million yuan, a decrease of 93.07% compared to the same period last year. The basic earnings per share was 0.0112 yuan.